Lupus

Journal

Publication Venue For

  • Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.  29:1095-1105. 2020
  • Remission and low disease activity state prevent hospitalizations in systemic lupus erythematosus patients.  28:1344-1349. 2019
  • Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.  28:1101-1110. 2019
  • Lupus: the new epidemic.  28:1031-1050. 2019
  • Lupus is associated with poorer outcomes after primary total hip arthroplasty.  28:834-842. 2019
  • Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort.  28:423-426. 2019
  • A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients.  27:1753-1754. 2018
  • Predictive factors of flares in systemic lupus erythematosus patients: data from a multiethnic Latin American cohort.  27:536-544. 2018
  • A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus.  26:1483-1490. 2017
  • Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL).  26:1368-1377. 2017
  • The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients.  26:1051-1059. 2017
  • Prolactin levels are associated with a pro-inflammatory body mass distribution among women with systemic lupus erythematosus.  26:808-814. 2017
  • A unique antiphospholipid assay recognizing phospholipid mixture compared with criteria antiphospholipid immunoassays in lupus patients.  26:606-615. 2017
  • Factors associated with disease expression patterns in systemic lupus erythematosus patients: Results from LUMINA (LXXVII), a multiethnic US cohort.  26:650-655. 2017
  • The caregiver burden in lupus: Findings from UNVEIL, a national online lupus survey in the United States.  26:54-61. 2017
  • Gender differences in disease activity and clinical features in newly diagnosed systemic lupus erythematosus patients.  25:1217-1223. 2016
  • Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients.  25:233-240. 2016
  • Lupus in Latin-American patients: Lessons from the GLADEL cohort.  24:536-545. 2015
  • Anti-C1q antibodies in systemic lupus erythematosus.  24:42-49. 2015
  • Late-onset systemic lupus erythematosus in Latin Americans: A distinct subgroup?.  24:788-795. 2015
  • What investigations are needed to optimally monitor for malignancies in SLE?.  24:781-787. 2015
  • High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients.  23:969-974. 2014
  • The American College of Rheumatology and the Systemic Lupus International Collaborating Clinics Classification criteria for systemic lupus erythematosus in two multiethnic cohorts: A commentary.  23:3-9. 2014
  • Spanish LupusPRO: Cross-cultural validation study for lupus.  22:431-436. 2013
  • Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes..  22:1214-1224. 2013
  • Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: Data from a Latin American cohort.  22:899-907. 2013
  • Mechanisms involved in the p62-73 idiopeptide-modulated delay of lupus nephritis in SNF1 mice.  21:1552-1564. 2012
  • Pseudo-pseudo Meigs' syndrome in a patient with systemic lupus erythematosus.  21:1463-1466. 2012
  • The impact of rural residency on the expression and outcome of systemic lupus erythematosus: Data from a multiethnic Latin American cohort.  21:1397-1404. 2012
  • Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: Data from LUMINA (LXXV), a multiethnic US cohort.  21:830-835. 2012
  • 17β-Estradiol (E-2) administration to male (NZB × SWR)F 1 mice results in increased Id LNF 1-reactive memory T-lymphocytes and accelerated glomerulonephritis.  21:288-301. 2012
  • Using Wii Fit to reduce fatigue among African American women with systemic lupus erythematosus: A pilot study.  20:1293-1299. 2011
  • International consensus for a definition of disease flare in lupus.  20:453-462. 2011
  • Autoantibodies in systemic lupus erythematosus: Comparison of historical and current assessment of seropositivity.  20:250-255. 2011
  • Strategic involvement of facial colliculus in SLE.  20:332-333. 2011
  • Is familial lupus different from sporadic lupus? Data from LUMINA (LXXIII), a multiethnic US cohort.  19:1331-1336. 2010
  • Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX.  19:727-733. 2010
  • Central variant of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: New associations?.  19:225-226. 2010
  • Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX)..  18:1303-1308. 2009
  • Factors associated with arterial vascular events in PROFILE: A multiethnic lupus cohort.  18:958-965. 2009
  • Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: Data from North and South America, Spain and Portugal.  18:1033-1036. 2009
  • Time to neuropsychiatric damage occurrence in LUMINA (LXVI): A multi-ethnic lupus cohort.  18:822-830. 2009
  • Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII).  18:184-186. 2009
  • Lessons from LUMINA: A multiethnic US cohort.  17:971-976. 2008
  • Adolescent onset of lupus results in more aggressive disease and worse outcomes: Results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII).  17:314-322. 2008
  • Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort.  17:177-184. 2008
  • Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: Data from an international inception cohort.  16:731-735. 2007
  • Peripheral vascular disease in systemic lupus erythematosus.  16:720-723. 2007
  • New treatment strategies for proliferative lupus nephritis: Keep children in mind!.  16:684-691. 2007
  • Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials.  16:418-425. 2007
  • Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: Factors predictive of pulmonary damage.  16:410-417. 2007
  • Acute granulomatous lupus pneumonitis: The first case report.  16:201-204. 2007
  • Discontinuation rate and factors predictive of the use of hydroxychloroquine in LUMINA, a multiethnic US cohort (LUMINA XL) [3].  15:700-704. 2006
  • Systemic lupus erythematosus in a multiethnic cohort (LUMINAXXXIX): Relationship between hormone replacement therapy and disease activity over time [2].  15:621-622. 2006
  • Erratum: Systemic Lupus Erythematosus in a Multi-ethnic Cohort (LUMINA) XXXII: Contributions of admixture and socioeconomic status to renal involvement (Lupus (2006) 15 (26-31)).  15. 2006
  • Cyclophosphamide use and pregnancy in lupus [3].  15:59. 2006
  • Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA): Contributions of admixture and socioeconomic status to renal involvement.  15:26-31. 2006
  • Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXVII: Factors predictive of a decline to low levels of disease activity.  15:13-18. 2006
  • Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXXI: Factors associated with patients being lost to follow-up.  15:19-25. 2006
  • Sweet syndrome as an initial presentation in a child with systemic lupus erythematosus [1].  14:974-975. 2005
  • Ethnic disparities in health and disease: The need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI) [1].  14:867-868. 2005
  • Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: A preliminary report.  14:137-144. 2005
  • Relationship between adherence to study and clinic visits in systemic lupus erythematosus patients: Data from the LUMINA cohort.  13:561-568. 2004
  • Can the weighted criteria improve our ability to capture a larger number of lupus patients into observational and interventional studies? A comparison with the American College of Rheumatology Criteria.  12:468-470. 2003
  • Clinical, immunogenetic and outcome features of hispanic systemic lupus erythematosus patients of different ethnic ancestry.  12:377-385. 2003
  • Systemic lupus erythematosus in three ethnic groups: XV prevalence and correlates of fibromyalgia.  12:274-279. 2003
  • Baseline characteristics of a multiethnic lupus cohort: PROFILE.  11:95-101. 2002
  • Conservation of FcεRI gamma chain coding region in normals and in SLE patients.  11:42-45. 2002
  • Erratum: Baseline characteristics of a multiethnic lupus cohort: PROFILE (Lupus (2002) 11 (95)).  11:402. 2002
  • SLE in three ethnic groups XIII. The 'weighted' criteria as predictors of damage.  11:329-331. 2002
  • Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis.  11:152-160. 2002
  • Protein-losing enteropathy in a young African-American woman with abdominal pain, diarrhea and hydronephrosis.  10:835-840. 2001
  • Of ethnicity, race and lupus.  10:594-596. 2001
  • Treatment of lupus with corticosteroids.  10:140-147. 2001
  • Cluster analysis of antinuclear autoantibodies in the prognosis of SLE nephropathy: Are anti-extractable nuclear antibodies protective?.  9:437-444. 2000
  • Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus.  9:132-139. 2000
  • Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis.  9:101-109. 2000
  • Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture..  9:101-109. 2000
  • Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort.  8:197-209. 1999
  • Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture..  8:197-209. 1999
  • Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes from patients with systemic lupus erythematosus.  7:515-523. 1998
  • Restriction fragment length polymorphisms of constant region genes of immunoglobulin lambda chains in Venezuelan patients with systemic lupus erythematosus.  5:300-302. 1996
  • International Standard Serial Number (issn)

  • 0961-2033
  • Electronic International Standard Serial Number (eissn)

  • 1477-0962